from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1096/-

LFCtreatmentdescriptionclass of inhibitor

-0.981

Amikacinug/mL Amikacintranslation

1.296

Cap5-10ug/mL Capreomycintranslation

0.519

Rox10-50 ug/mL Roxithromycintranslation

0.797

SM2-5 ug/mL Streptomycintranslation

-1.239

Tet5-10 ug/mL Tetracyclinetranslation

-0.982

Rif0.2-5ug/mL Rifampicintranscription

-0.110

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.180

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.180

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.274

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.468

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.083

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.334

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.949

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.807

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.143

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.703

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.659

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.690

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.888

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.552

KCN5-20 ug/mL Potassium cyaniderespiration

-1.749

NaN30.2-2 mM Sodium aziderespiration

1.141

Nigericin50 uM Nigericinrespiration

-1.437

TRC10-150 ug/mL Triclosanrespiration

-0.101

TRZ10-25 ug/mL Thioridazinerespiration

2.495

Valinomycin0.5-10 uM Valinomycinrespiration

1.584

ZnSO42 mM ZnSO4respiration

-0.051

menadione6-10 ug/mL Menadionerespiration

0.431

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.623

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.460

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.250

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.015

NRP_1Non-replicating persistence stage 1dosRassociated

0.980

Amp0.2mg/mL AmpicillincellWall

0.544

Cephalexin20-100 ug/mL CephalexincellWall

1.265

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.154

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.444

EMB10-20 ug/mL EthambutolcellWall

0.358

Eta12-40 ug/mL EthionamidecellWall

0.148

INH0.2-0.4 ug/mL IsoniazidcellWall

0.105

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.142

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.316

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.756

BZA0.12 mg/mL BenzamidearomaticAmides

-0.418

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.039

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.036

H2O24 mM hydrogen peroxideDNAdamaging

0.813

Levo10 ug/mL LevofloxacinDNAdamaging

0.164

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.722

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.186

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.081

UVUV-irradiationDNAdamaging

-1.481

ARP41-4 ug/mL Antitubercular compound ARP4?

0.582

Antimycin12.5-50 ug/mL Antimycin A?

1.018

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.533

PA_110-50 ug/mL Antitubercular compound PA-1?

0.273

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.782

PA8240.2-2 ug/mL PA-824?

-0.489

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.142

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.793

Verapamil50 uM Verapamil?

-0.243

mercaptoethanol2 mM 2-Mercaptoethanol?

1.152

methoxatin10-20 ug/mL Methoxatin?